-
Symbol
-
ATXI on OTC
-
Investment type
-
Equity / Common Stock, $0.0001 Par Value
-
Latest Disclosed Ownership
-
329K shares
-
Security Ownership
-
10.3%
Fortress Biotech, Inc. ownership in AVENUE THERAPEUTICS, INC. Common Stock, $0.0001 Par Value (ATXI)
2025-04-02 - Fortress Biotech, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 329K shares of AVENUE THERAPEUTICS, INC. Common Stock, $0.0001 Par Value (ATXI).
This represents 10.3% percent ownership of the company.
In their previous filing dated 2025-01-03, Fortress Biotech, Inc. had reported owning 295K shares, indicating an increase of 11.4% percent.